Sensitive western blotting for detection of endogenous Ser129-phosphorylated α-synuclein in intracellular and extracellular spaces
Authors:
Open Access
- 18 September 2015
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 14211
Abstract
α-Synuclein deposited in Lewy bodies, a pathological hallmark of Parkinson’s disease (PD), is highly phosphorylated at serine 129 (Ser129). In contrast, there is very little Ser129-phosphorylated α-synuclein in the normal brains. This difference suggests that Ser129-phosphorylation is involved in neurodegenerative processes of PD. However, the role of this modification remains unclear. One limiting factor for relevant biochemical analyses is that it is difficult to detect endogenous Ser129-phosphoryated α-synuclein by western blotting, because α-synuclein monomers detached from the transferred membrane during incubation. Here, we reported that combination fixation of the transferred membrane with 4% paraformaldehyde and 0.01 ~ 0.1% glutaraldehyde produced an approximately 10-fold increase in the sensitivity for Ser129-phosphorylated α-synuclein monomers, allowing detection of endogenous proteins even in conditioned medium, human cerebrospinal fluid and extracts from cell lines and human brain. This method may enable more detailed biochemical analyses for α-synuclein transmission between intra and extracellular spaces under physiological and pathological conditions.Keywords
This publication has 27 references indexed in Scilit:
- A New Method for Quantitative Immunoblotting of Endogenous α-SynucleinPLOS ONE, 2013
- A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's diseaseScientific Reports, 2013
- Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivoProceedings of the National Academy of Sciences, 2013
- Serine 129 phosphorylation of membrane-associated α-synuclein modulates dopamine transporter function in a G protein–coupled receptor kinase–dependent mannerMolecular Biology of the Cell, 2013
- Phosphorylated α-Synuclein in Parkinson’s DiseaseScience Translational Medicine, 2012
- Authentically Phosphorylated α-Synuclein at Ser129 Accelerates Neurodegeneration in a Rat Model of Familial Parkinson's DiseaseJournal of Neuroscience, 2011
- Improved Immunodetection of Endogenous α-SynucleinPLOS ONE, 2011
- Phosphorylated α-Synuclein at Ser-129 Is Targeted to the Proteasome Pathway in a Ubiquitin-independent MannerJournal of Biological Chemistry, 2010
- Parkinson's Disease-Related Protein, α-Synuclein, in Malignant MelanomaPLOS ONE, 2010
- Regulation of Smoothened by Drosophila G-protein-coupled receptor kinasesDevelopmental Biology, 2010